ARTIFICIAL ORGAN MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026-2033)
Segmentation
By Organ TypeArtificial Heart (Ventricular Assist Devices (VADs), Total Artificial Hearts (TAHs)) · Artificial Kidney (Wearable Artificial Kidneys, Implantable Renal Devices) · Artificial Liver (Bioartificial Liver Support Systems, Artificial Pancreas, Artificial Lungs, Sensory Organs, Corneal Implants, and Others (Neuro-Controlled Prostheses)) · By Patient Type (Neonates, Pediatric, and Adult) · By End User (Hospitals, Transplant Centers, Ambulatory Surgical Centers, Emergency and Trauma Centers, Home Care Settings, and Others (Research Institutes, etc.)) · By Application (Transplantation, Chronic Disease Management, and Other Emergency or Acute Care) · By Technology (Mechanical, Electronic or Bionic, Biomechanical Hybrid, Biomaterials-Based Technology (e.g., Decellularized Scaffolds, 3D-Bioprinted Tissues), and Others) · By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa
Published In11 Mar 2026
Report CodeCMI8264
Pages250+
FormatsExcel and PDF
Base Year2025
Estimated Year2026
Historical Range2020 - 2024
Forecast Period2026-2033
Market Segmentation
Organ Type Insights (Revenue, USD Bn, 2021 - 2033)
Artificial Heart
Ventricular Assist Devices (VADs)
Total Artificial Hearts (TAHs)
Artificial Kidney
Wearable Artificial Kidneys
Implantable Renal Devices
Artificial Liver
Bioartificial Liver Support Systems
Extracorporeal Liver Assist Devices
Artificial Pancreas
Closed-Loop Insulin Delivery Systems
Implantable Glucose Monitors
Artificial Lungs
Extracorporeal Membrane Oxygenation (ECMO)
Implantable Oxygenators
Sensory Organs
Cochlear Implants (Hearing)
Retinal Implants (Vision)
Corneal Implants
Bionic Limbs
Myoelectric Prosthetics
Others (Neuro-Controlled Prostheses)
Patient Type Insights (Revenue, USD Bn, 2021 - 2033)
